Nov 06, 2017 13:34 pm UTC| Business
MONACO, Nov. 06, 2017 -- Navios Maritime Holdings Inc. (“Navios Holdings” or the “Company”) (NYSE:NM) announced today that the Company and Navios Maritime Finance II (US) Inc., its wholly owned finance subsidiary,...
Nov 06, 2017 13:33 pm UTC| Business
MONACO, Nov. 06, 2017 -- Navios Maritime Holdings Inc. ("Navios Holdings" or "the Company") (NYSE:NM), a global, vertically integrated seaborne shipping and logistics company, today filed a 6-K with the Securities and...
Fenix Outdoor Accelerates International Omnichannel Expansion with Manhattan Associates
Nov 06, 2017 13:33 pm UTC| Business
NIEUWEGEIN, The Netherlands and ATLANTA, Nov. 06, 2017 -- Fenix Outdoor Group, a subsidiary of Switzerland-based outdoor goods specialist Fenix Outdoor International AG, has selected Manhattan Associates, Inc....
Nov 06, 2017 13:32 pm UTC| Business
WILMINGTON, Del., Nov. 06, 2017 -- Acorn Energy, Inc. (OTCQB:ACFN), a provider of machine-to-machine, Internet of Things (IoT) remote monitoring and control systems and services, will host a conference call to review...
Cemtrex Signs Letter of Intent to Acquire Virtual Reality Software Studio
Nov 06, 2017 13:32 pm UTC| Business
Farmingdale, NY, Nov. 06, 2017 -- Cemtrex Inc., (NASDAQ: CETX, CETXP, CETXW) has signed a letter of intent to acquire a virtual reality software development studio headquartered in New York City. This virtual reality...
Nov 06, 2017 13:31 pm UTC| Business
-- Nationwide Children’s Hospital to initiate a Phase 1/2a clinical trial at potentially therapeutic doses in children with DMD by mid-November 2017 -- -- First micro-dystrophin gene therapy program in clinical...
Anthera Pharmaceuticals Provides Business Update and Reports 2017 Third Quarter Financial Results
Nov 06, 2017 13:31 pm UTC| Business
RESULT, Phase 3 clinical study of Sollpura, topline data expected Q1 2018RESULT sanctioned by the European Cystic Fibrosis Society Clinical Trial NetworkBlisibimod granted FDA orphan drug designation for the treatment of...